Back

Protective effects of COVID-19 vaccination on endothelial function of patients with COVID-19

29 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Cardiovascular aspects of COVID and long-COVID Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Evangelos Oikonomou

National & Kapodistrian University of Athens, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19
Doctor J. Quintal (Setubal, PT)
Abstract Slides
Presentation thumbnail
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation
Mrs C. Eyileten (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19
Mrs E. Rosendahl (Solna, SE)
Abstract Slides
Presentation thumbnail
Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation.
Associate Professor M. Camera (Milan, IT)
Abstract Slides
Presentation thumbnail
Dysregulation of cardiac endothelial lncRNA H19 in COVID19 patients induces endothelial dysfunction, which impairs cardiomyocyte function
Doctor R. Juni (Amsterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular aspects of COVID and long-COVID

The Event

Event poster

ESC Congress 2022

29 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection.
thumbnail
Congress Presentation
Association between endothelial dysfunction and pulmonary function in patients with post SARS-COV-2 infection
thumbnail
Congress Presentation
Prior COVID-19 infection is associated with persistent and higher thrombus burden in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources